Heparin Resistance and Antithrombin: Should It Still Be Called Heparin Resistance?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 18, Issue 2, 2004, Pages 129-130

  Levy, Jerrold H ^a,b  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; HEPARIN; SERINE PROTEINASE INHIBITOR; THROMBIN INHIBITOR;

ANTICOAGULATION; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVATION; EDITORIAL; HEART SURGERY; HEMOSTASIS; HEPARINIZATION; HUMAN; NOMENCLATURE; PATHOPHYSIOLOGY; PLASMA TRANSFUSION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

EID: 1942454849     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2004.01.013     Document Type: Editorial

References (20)

1. Levy JH: Pharmacologic preservation of the hemostatic system during cardiac surgery. Ann Thorac Surg 72:S1814-1820, 2001
2. Despotis GJ, Filos K, Gravlee G, et al: Anticoagulation monitoring during cardiac surgery: A survey of current practice and review of current and emerging techniques. Anesthesiology 91:1122-1151, 1999
3. Despotis GJ, Avidan M, Hogue CW: Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 72:S1821-1831, 2001
4. Despotis GJ, Joist JH: Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: An update. J Cardiothorac Vasc Anesth 13:18-29, 1999 (suppl 1)
5. Staples MH, Dunton RF, Karlson KJ, et al: Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping. Ann Thorac Surg 57:1211-1216, 1994
6. Despotis GJ, Levine V, Joist JH, et al: Antithrombin III during cardiac surgery: Effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation. Anesth Analg 85:498-506, 1997
7. Shore-Lesserson L, Manspeizer HE, Bolastig M, et al: Anticoagulation for cardiac surgery in patients receiving preoperative heparin: Use of the high-dose thrombin time. Anesth Analg 90:813-818, 2000
8. Williams MR, D'Ambra AB, Beck JR, et al: A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg 70:873-877, 2000
9. Ranucci M, Isgro G, Cazzaniga A, et al: Predictors for heparin resistance in patients undergoing coronary artery bypass grafting. Perfusion 14:437-442, 1999
10. Levy JH, Montes F, Szlam F, et al: The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapy. Anesth Analg 90:1076-1079, 2000
11. Dietrich W, Spannagl, Schramm W, et al: The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg 102:505-514, 1991
12. Esposito RA, Culliford AT, Colvin SB, et al: Heparin resistance during cardiopulmonary bypass: The role of heparin pretreatment. J Thorac Cardiovasc Surg 85:346-353, 1983
13. Cloyd GM, D'Ambra MN, Akins CW: Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 94:535-538, 1987
14. Lemmer JH, Despotis GJ: Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 123:213-217, 2002
15. Koster A, Fischer T, Gruendel M, et al: Management of heparin resistance during cardiopulmonary bypass: The effect of five different anticoagulation strategies on hemostatic activation. J Cardiothorac Vasc Anesth 17:171-175, 2003
16. Hashimoto K, Yamagishi M, Sasaki T, et al: Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation. Ann Thorac Surg 58:799-804, 1994
17. Weitz JI: Low-molecular-weight heparins. N Engl J Med 337: 688-699, 1997
18. Lindahl U, Backstrom G, Hook M, et al: Structure of the antithrombin binding site in heparin. Proc Natl Acad Sci USA 76:3198-3202, 1979
19. Levy JH, Despotis GJ, Szlam F, et al: Recombinant human transgenic antithrombin in cardiac surgery: A dose-finding study. Anesthesiology 96:1095-1102, 2002
20. Zaidan JR, Johnson S, Brynes R, et al: Rate of protamine administration: Its effect on heparin reversal and antithrombin recovery after coronary artery surgery. Anesth Analg 65:377-380, 1986